TABLE OF CONTENTS
1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT SCOPE
1.3 RESEARCH METHODOLOGY
1.4 KEY DATA POINTS FROM SECONDARY SOURCES
2 EXECUTIVE SUMMARY
3 METABOLOMICS –TECHNOLOGY LANDSCAPE ANALYSIS
3.1 INTRODUCTION
3.2 METABOLOMICS AND METABONOMICS
3.3 SEPARATION TECHNIQUES – HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
3.4 SEPARATION TECHNIQUES – CAPILLARY ELECTROPHORESIS (CE)
3.5 DETECTION TECHNIQUES – MASS SPECTROMETRY (MS)
3.6 DETECTION TECHNIQUES – NUCLEAR MAGNETIC RESONANCE (NMR)
3.7 DETECTION TECHNIQUES – SURFACE BASED MASS ANALYSIS
3.8 KEY APPLICATION AREAS
3.8.1 BIOMARKER DISCOVERY
3.8.2 DRUG DISCOVERY
3.8.3 TOXICITY ASSESSMENT/TOXICOLOGY
3.8.4 NUTRI-GENOMICS
3.9 CONCEPTUAL APPROACH
3.9.1 TARGET ANALYSIS
3.9.2 METABOLITE PROFILING
3.9.3 METABOLITE FINGERPRINTING
3.10 TECHNOLOGY TRENDS IN METABOLOMICS
3.11 VALUE CHAIN ANALYSIS
4 METABOLOMICS – MARKET LANDSCAPE ANALYSIS
4.1 GLOBAL METABOLOMICS MARKET SEGMENTATION
4.2 MARKET FORECAST
4.2.1 GLOBAL METABOLOMICS MARKET REVENUE FORECAST – INTRODUCTION
4.2.2 GLOBAL METABOLOMICS MARKET REVENUE – REGIONAL
4.2.3 GLOBAL METABOLOMICS MARKET REVENUE – INDICATION
4.2.4 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION
4.3 MARKET DYNAMICS
4.3.1 DRIVERS
4.3.2 RESTRAINTS
4.3.3 CHALLENGES
4.3.4 EMERGING TRENDS
4.4 DEMAND SIDE ANALYSIS
5 METABOLOMICS – TECHNOLOGY INVESTMENT POTENTIAL 70-81
5.1 INVESTMENT CLIMATE ASSESSMENT
5.1.1 INVESTMENT CLIENT NETWORKS
5.1.1.1 FUNDING BODIES
5.1.1.2 INSIGHTS ON CURRENT & FUTURE TECH-INVESTMENT TREND
5.1.2 FUNDING OPPORTUNITIES
5.1.3 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION
6 METABOLOMICS – GEOGRAPHICAL ANALYSIS
6.1 INTRODUCTION
6.2 U.S., CANADA, MEXICO
6.3 EUROPE
6.4 ASIA & REST OF THE WORLD (ROW)
7 COMPETITIVE LANDSCAPE ANALYSIS
7.1 MERGERS & ACQUISITIONS
7.2 NEW PRODUCT DEVELOPMENTS
7.3 COLLABORATIONS
8 PATENT ANALYSIS
8.1 PATENT ANALYSIS
9 TECHNOLOGY ANALYSIS (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING 94-100
9.1 LEVEL 0 CRITERIA DESCRIPTION
9.2 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA
9.3 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS
9.4 TECHNOLOGY ROADMAP
10 ANALYST INSIGHTS & RECOMMENDATIONS
10.1 ANALYST INSIGHTS
10.2 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT
11 COMPANY PROFILES
11.1 AGILENT TECHNOLOGIES
11.2 BRUKER CORPORATION
11.3 METABOLOMIC TECHNOLOGIES
11.4 METABOLON
11.5 CHENOMX
11.6 BIO-RAD LABORATORIES
11.7 WATERS CORPORATION
11.8 HUMAN METABOLOME TECHNOLOGIES
11.9 NEXTGEN METABOLOMICS
11.10 BIOCRATES LIFE SCIENCES AG
11.11 STEMINA BIOMARKER
11.12 PHENOMENOME
11.13 METANOMICS GMBH
11.14 ACCELRYS
11.15 EISAI CO. LTD.
11.16 SHIMADZU CORPORATION
11.17 SIDMAP, LLC
11.18 ASTRAZENECA PLC
11.19 AB SCIEX
11.2 METABOLOMX
11.21 RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC)
12 APPENDIX
12.1 KEY PATENTS
13 GLOSSARY
LIST OF TABLESTABLE 1 GLOBAL METABOLOMICS MARKET REVENUE, BY REGIONAL ($MILLION)
TABLE 2 GLOBAL METABOLOMICS MARKET REVENUE, BY INDICATION ($MILLION)
TABLE 3 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY ONCOLOGY INDICATION
TABLE 4 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY CARDIOLOGY INDICATION
TABLE 5 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY NEUROLOGY INDICATION
TABLE 6 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER INDICATIONS
TABLE 7 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION ($MILLION)
TABLE 8 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY BIO MARKER DISCOVERY APPLICATION
TABLE 9 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY DRUG DISCOVERY APPLICATION
TABLE 10 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY TOXICOLOGY TESTING APPLICATION
TABLE 11 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER APPLICATIONS
LIST OF OTHER TABLES
TABLE 1 MARKET DYNAMICS-DRIVERS IMPACT BY TIMELINE
TABLE 2 MARKET DYNAMICS-RESTRAINTS IMPACT BY TIMELINE
TABLE 3 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
TABLE 4 MERGERS AND ACQUISITIONS
TABLE 5 NEW PRODUCT DEVELOPMENTS
TABLE 6 COLLABORATIONS
TABLE 7 KEY PATENTS
LIST OF FIGURES
FIG 1 RESEARCH METHODOLOGY
FIG 2 GLOBAL METABOLOMICS MARKET REVENUE, 2012 - 2017 ($MILLION)
FIG 3 MARKET SHARE BY REGION, 2012 - 2017 (%)
FIG 4 KEY APPLICATION AREAS
FIG 5 FLOW CHART OF NUTRI-GENOMICS
FIG 6 CONCEPTUAL APPROACH
FIG 7 VALUE CHAIN ANALYSIS
FIG 8 PERCENTAGE OF STAKE HOLDERS IN METABOLOMICS VALUE CHAIN
FIG 9 GLOBAL METABOLOMICS MARKET SEGMENTATION
FIG 10 GLOBAL METABOLOMICS MARKET REVENUE FORECAST, 2012 - 2017 ($MILLION)
FIG 11 GLOBAL METABOLOMICS MARKET REVENUE, BY REGIONAL ($MILLION)
FIG 12 GLOBAL METABOLOMICS MARKET Y-O-Y GROWTH RATE, BY REGION
FIG 13 MARKET SHARE, BY REGION, 2012 - 2017 (%)
FIG 14 GLOBAL METABOLOMICS MARKET REVENUE, BY INDICATION ($MILLION)
FIG 15 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY ONCOLOGY INDICATION
FIG 16 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY CARDIOLOGY INDICATION
FIG 17 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY NEUROLOGY INDICATION
FIG 18 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER INDICATIONS
FIG 19 GLOBAL MARKET SHARE, BY INDICATION, 2012 - 2017 (%)
FIG 20 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION ($MILLION)
FIG 21 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY BIO MARKER DISCOVERY APPLICATION
FIG 22 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY DRUG DISCOVERY APPLICATION
FIG 23 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY TOXICOLOGY TESTING APPLICATION
FIG 24 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER APPLICATIONS
FIG 25 GLOBAL PERCENTAGE DISTRIBUTION OF METABOLOMICS MARKET, BY APPLICATIONS, 2012 - 2017 (%)
FIG 26 DEMAND SIDE ANALYSIS
FIG 27 INVESTMENT CLIENT NETWORKS
FIG 28 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS
FIG 29 REGIONS WITH HIGH TECHNOLOGY ADOPTION
FIG 30 PATENT DISTRIBUTION AMONG TOP PLAYERS
FIG 31 AHP ANALYSIS
FIG 32 PRIORITY VALUES
FIG 33 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA
FIG 34 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS
FIG 35 TECHNOLOGY ROADMAP
FIG 36 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT